Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
AI Sleep Analysis Methodology Shows Promise for Early Alzheimer’s Detection
3+ hour, 14+ min ago (456+ words) Jul 29, 2026 | AI & Machine Learning, Brain, Circadian & Sleep Biomarkers | 0 | Researchers from Universidad Carlos III de Madrid (UC3M) and Hospital Universitario Severo Ochoa have developed a methodology utilizing artificial intelligence (AI) to analyze brain electrical activity during sleep, aiming to facilitate the early…...
Surprising Heart Rate Variability Findings in Afib-Sleep Apnea Study
3+ hour, 50+ min ago (305+ words) Jul 29, 2026 | Breathing Disorders, Heart | 0 | Disordered sleep might harm the heart more during the day than at night, according to a study published in the Journal of Arrhythmia. The findings could help improve the treatment of atrial fibrillation. Over time, sleep…...
Phase 3 Trials Show Weight Loss for Triple Agonist with OSA Potential
1+ day, 4+ hour ago (210+ words) Jul 28, 2026 | Emerging Compounds, Obstructive Sleep Apnea | 0 | Eli Lilly and Company recently shared positive topline results from two pivotal phase 3 trials evaluating retatrutide, an investigational, first-in-class GIP, GLP-1, and glucagon triple hormone receptor agonist. The results from the TRIUMPH-2 and TRIUMPH…...
Burke Rehabilitation Awarded Grant to Study OSA in Brain Disorder Patients
4+ day, 3+ hour ago (370+ words) Sleep Review The $75,000 grant from the Resmed Foundation will fund a clinical research project examining how obstructive sleep apnea impacts recovery in inpatient rehabilitation settings Key takeaways: The study will estimate obstructive sleep apnea prevalence among inpatient rehabilitation patients with…...
Participant Screening Begins for Phase 2 Study of Novel OSA Therapy
4+ day, 16+ hour ago (270+ words) Sleep Review Incannex Healthcare has initiated screening for its DReAMzz dose confirmation study evaluating IHL-42X for obstructive sleep apnea Key takeaways: Screening is underway for the DReAMzz phase 2 study of IHL-42X, an investigational oral therapy for OSA with FDA Fast…...
FDA Grants Fast Track Designation to Investigational Narcolepsy Treatment
6+ day, 3+ hour ago (157+ words) Jul 23, 2026 | Emerging Compounds, FDA, Narcolepsy | 0 | The US Food and Drug Administration (FDA) granted Fast Track designation to Lu AH69593, an investigational oral orexin 2 receptor agonist in development by Lundbeck for the treatment of narcolepsy. Discovered by Lundbeck, the small-molecule compound is…...
FDA Issues Warning Letter Over APAPs
1+ week, 1+ day ago (142+ words) Jul 20, 2026 | CPAP & PAP Devices, FDA | 0 | Following an inspection of React Health’s Dublin, Ohio, facility in December 2025, the FDA determined BMC Medical is the specification developer and 510(k) owner of the devices in question. The FDA letter details that firmware and…...
Surprisingly, Snoring Vibrations May Themselves Fuel Sleep Apnea Progression
1+ week, 4+ day ago (251+ words) Jul 17, 2026 | Obstructive Sleep Apnea, Snoring | 0 | Snoring is widely recognized as a primary symptom of obstructive sleep apnea (OSA), but new research indicates it may also play a direct role in the development of the disease. Researchers at Umeå University have…...
Wearable Device Could Enable Glymphatic Clearance Monitoring During Sleep
1+ week, 5+ day ago (311+ words) Sleep Review Georgia Tech researchers developed a wireless wearable to track physiological changes linked with sleep and brain health in the home setting Key takeaways: A newly developed soft, wireless wearable uses near-infrared spectroscopy to monitor brain water and glymphatic…...
Why Microsleeps May Redefine ‘Quality of Wake’ in Narcolepsy Type 1
1+ week, 6+ day ago (487+ words) Jul 16, 2026 | MSLT, MWT & Other Studies, Narcolepsy | 0 | In the context of clinical trials, mean sleep onset latency provides a clear, quantifiable number that regulatory bodies can use to evaluate whether a drug helps a patient stay awake longer. Yet, in clinical…...